During the past decade, Canadian Phase Onward Inc conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 16 clinical trials were completed, i.e. on average, 84.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Canadian Phase Onward Inc" #1 sponsor was "Pfizer" with 6 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Dynogen Pharmaceuticals" with 3 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Canadian Phase Onward Inc" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Veristat, Inc." with 2 trials as a collaborator, "Assurex Health Ltd." with 1 trials as a collaborator, "Centre for Addiction and Mental Health" with 1 trials as a collaborator and "Genome Canada" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Canadian Phase Onward Inc" are "Smoking Cessation" (4 trials), "Irritable Bowel Syndrome" (3 trials), "Cardiovascular Disease" (2 trials), "Depressive Disorder, Major" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Canadian Phase Onward Inc" in a lesser frequency.

Most popular intervention types in "Canadian Phase Onward Inc" are "Drug" (26 trials), "Other" (5 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "DDP733" (2 trials), "Empagliflozin" (2 trials), "Nicotine Replacement Therapy Patch" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Canadian Phase Onward Inc" are 29 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Canadian Phase Onward Inc". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Canadian Phase Onward Inc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Canadian Phase Onward Inc, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".